56.69
Radnet Inc stock is traded at $56.69, with a volume of 1.03M.
It is up +0.27% in the last 24 hours and down -0.75% over the past month.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
See More
Previous Close:
$56.54
Open:
$56.71
24h Volume:
1.03M
Relative Volume:
1.54
Market Cap:
$4.25B
Revenue:
$1.77B
Net Income/Loss:
$-4.41M
P/E Ratio:
-809.86
EPS:
-0.07
Net Cash Flow:
$83.27M
1W Performance:
-3.16%
1M Performance:
-0.75%
6M Performance:
-16.61%
1Y Performance:
-5.01%
Radnet Inc Stock (RDNT) Company Profile
Name
Radnet Inc
Sector
Industry
Phone
(310) 478-7808
Address
1510 COTNER AVE, LOS ANGELES, CA
Compare RDNT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
RDNT
Radnet Inc
|
56.69 | 4.35B | 1.77B | -4.41M | 83.27M | -0.07 |
![]()
TMO
Thermo Fisher Scientific Inc
|
477.28 | 182.01B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
203.99 | 148.12B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
572.09 | 46.09B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
118.05 | 34.04B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.54 | 33.07B | 15.50B | 1.33B | 2.16B | 7.34 |
Radnet Inc Stock (RDNT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-13-25 | Initiated | B. Riley Securities | Buy |
Mar-05-25 | Upgrade | Raymond James | Outperform → Strong Buy |
Sep-06-24 | Upgrade | Barclays | Equal Weight → Overweight |
Mar-06-24 | Initiated | Barclays | Equal Weight |
Aug-31-23 | Initiated | Truist | Buy |
Mar-31-23 | Initiated | CJS Securities | Market Outperform |
Mar-03-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
Aug-12-21 | Initiated | Barclays | Overweight |
Mar-15-19 | Downgrade | Raymond James | Strong Buy → Outperform |
Mar-14-18 | Initiated | Raymond James | Strong Buy |
Aug-22-17 | Upgrade | Jefferies | Hold → Buy |
Jun-02-16 | Initiated | Sterne Agee CRT | Neutral |
Apr-15-16 | Initiated | Sidoti | Buy |
Mar-17-09 | Reiterated | Jefferies & Co | Buy |
Oct-15-08 | Initiated | RBC Capital Mkts | Sector Perform |
Jul-14-08 | Upgrade | Stanford Research | Hold → Buy |
Apr-02-08 | Upgrade | Morgan Keegan | Mkt Perform → Outperform |
Mar-14-08 | Downgrade | Morgan Keegan | Outperform → Mkt Perform |
Dec-19-07 | Initiated | Leerink Swann | Outperform |
Dec-07-07 | Initiated | Stanford Research | Hold |
Nov-07-07 | Initiated | Morgan Keegan | Outperform |
Oct-19-07 | Initiated | Deutsche Securities | Buy |
Jun-18-07 | Reiterated | Jefferies & Co | Buy |
May-22-07 | Initiated | Jefferies & Co | Buy |
View All
Radnet Inc Stock (RDNT) Latest News
Why RadNet Inc. stock attracts strong analyst attentionEarly Breakout Entry Point Notifications Sent - metal.it
Lunit takes on RadNet’s AI empire as SimonMed switches breast cancer AI providers - koreabiomed.com
What is the risk reward ratio of investing in RadNet Inc. stockFree Stock Trend Scanner For 2025 - jammulinksnews.com
RadNet Inc. Stock Fails to Break Resistance Traders ReactRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
What catalysts could drive RadNet Inc. stock higher in 2025Real Time Alerts For Fast Growth - jammulinksnews.com
How RadNet Inc. stock performs during market volatilityPotential Breakout Stock List Published This Week - metal.it
What makes RadNet Inc. stock price move sharplyAchieve breakthrough profits with expert advice - jammulinksnews.com
How volatile is RadNet Inc. stock compared to the marketExplosive trading opportunities - jammulinksnews.com
Is RadNet Inc. a growth stock or a value stockInvest confidently with proven investment plans - jammulinksnews.com
Is it the right time to buy RadNet Inc. stockOver 200% growth - jammulinksnews.com
What analysts say about RadNet Inc. stockFastest-growing stock picks - PrintWeekIndia
Is RadNet Inc. stock a growth or value playSuperior capital gains - jammulinksnews.com
RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call | RDNT Stock News - GuruFocus
Leading Diagnostic Imaging Provider RadNet Sets Q2 2025 Earnings Release DateKey Details Inside - Stock Titan
RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call - GlobeNewswire
What drives RadNet Inc. stock priceExplosive returns - PrintWeekIndia
Will RadNet Inc. stock split in the near futureUnmatched market gains - jammulinksnews.com
RadNet Inc. Stock Analysis and ForecastRapid market gains - jammulinksnews.com
Is RadNet Inc. a good long term investmentOutstanding risk-reward balance - jammulinksnews.com
There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Price - 富途牛牛
RadNet's Acquisition of iCAD and the Future of AI in Breast Cancer Screening: Strategic AI Consolidation and Its Impact on Market Leadership and Scalability in Digital Health - AInvest
RadNet’s DeepHealth concludes iCAD acquisition - Yahoo Finance
RadNet Completes Acquisition of iCAD for AI Expansion - The Globe and Mail
RadNet Completes Acquisition of iCAD, Delisting from Nasdaq - The Globe and Mail
RadNet subsidiary DeepHealth acquires iCAD - AuntMinnieEurope
DeepHealth acquires iCAD - Medical Buyer
DeepHealth completes iCAD acquisition for breast cancer AI tools - healthcare-in-europe.com
Radnet Inc Stock (RDNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):